| 23rd Aug 2024 7:00 am |
RNS |
BNR Reports Second Quarter 2024 Financial Results |
| 19th Aug 2024 7:00 am |
RNS |
BNR Announces Expected Delisting of ADS |
| 29th May 2024 7:00 am |
RNS |
1st Quarter Results |
| 23rd May 2024 7:00 am |
RNS |
BNR Schedules 2024 Q1 Earnings Release on May 29 |
| 14th May 2024 7:00 am |
RNS |
BNR Announces ADS Ratio Change to Be Effective |
| 9th May 2024 7:00 am |
RNS |
Burning Rock ADS Ratio Change |
| 29th Apr 2024 8:12 am |
RNS |
BNR Publishes 2023 Annual Report on Form 20-F |
| 26th Apr 2024 7:00 am |
RNS |
Burning Rock Announces ADS Ratio Change |
| 2nd Apr 2024 7:00 am |
RNS |
BNR Reports 23Q4 and Full Year Financial Results |
| 4th Jan 2024 7:00 am |
RNS |
BNR Announces Receipt of Notification from NASDAQ |
| 20th Dec 2023 7:00 am |
RNS |
BNR Announces Results of 2023 AGM |
| 30th Nov 2023 7:00 am |
RNS |
BNR Reports Third Quarter 2023 Financial Results |
| 22nd Nov 2023 7:00 am |
RNS |
BNR Announces 2023 AGM to be Held on Dec 20, 2023 |
| 21st Nov 2023 7:00 am |
RNS |
BNR Schedules Q3 Earnings Release on Nov 30, 2023 |
| 30th Oct 2023 7:09 am |
RNS |
BNR and BI Achieved a Master Service Agreement |
| 16th Oct 2023 7:00 am |
RNS |
BNR Received Breakthrough Device Designation |
| 8th Sep 2023 7:00 am |
RNS |
Study results published in the Cancer Cell |
| 31st Aug 2023 7:00 am |
RNS |
BNR Reports Second Quarter 2023 Financial Results |
| 4th Aug 2023 8:27 am |
RNS |
BNR Schedules Earnings Release on August 31, 2023 |
| 28th Jun 2023 9:04 am |
RNS |
Announces Resignation and Appointment of Directors |
| 8th Jun 2023 7:00 am |
RNS |
Published in the New England Journal of Medicine |
| 30th May 2023 7:00 am |
RNS |
Burning Rock Reports 1st Quarter Financial Results |
| 27th Apr 2023 7:00 am |
RNS |
BNR Schedules Q1 Earnings Release on May 30, 2023 |
| 21st Apr 2023 7:00 am |
RNS |
BNR Publishes 2022 Annual Report on Form 20-F |
| 28th Mar 2023 7:00 am |
RNS |
Burning Rock Reports Q4 and Full Year 2022 Results |
| 7th Mar 2023 8:31 am |
RNS |
BNR Schedules 22Q4 and Full Year ER on March 28 |
| 18th Jan 2023 7:00 am |
RNS |
An update on 2022 revenue guidance |
| 3rd Jan 2023 2:53 pm |
RNS |
BNR Received FDA Breakthrough Device Designation |
| 16th Nov 2022 7:00 am |
RNS |
Burning Rock Third Quarter 2022 Financial Results |
| 8th Nov 2022 7:00 am |
RNS |
Prospectus Supplement Filed with U.S. SEC |
| 1st Nov 2022 9:54 am |
RNS |
Admission to Trading on the London Stock Exchange |
